Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 75/100

First patient dosed in Phase 1 therapeutic lung cancer trial

Friday, July 26, 2024 1 min read
Key Takeaway: Radiopharm Theranostics has announced the dosing of the first patient in its Phase 1 clinical trial for BetaBart (RV-01), a therapeutic targeting B7H3. This milestone follows the recent IND approval from the US FDA, marking a significant step in the development of this treatment for lung cancer.

Market Sentiment Analysis

POSITIVE FACTORS

  • First patient dosed in a Phase 1 clinical trial.
  • Focus on targeting B7H3 with BetaBart (RV-01).
  • IND approval received from the US FDA.

Full Press Release Details

• Announcements
• Price Sensitive
• July 26, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• June 30, 2025
• Announcements
• July 31, 2023
• Announcements
• February 6, 2024
• Announcements
• June 22, 2022

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is the purpose of the Phase 1 trial?

The Phase 1 trial aims to evaluate the safety and efficacy of BetaBart (RV-01) targeting B7H3 in lung cancer patients.

Who is conducting the clinical trial?

The clinical trial is being conducted by Radiopharm Theranostics.

What milestone was recently achieved?

The first patient has been dosed in the Phase 1 clinical trial.

What regulatory approval did Radiopharm receive?

Radiopharm received IND approval from the US FDA to initiate the Phase 1 study.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics BetaBart RV-01 B7H3 Phase 1 trial
Last updated: Jul 26, 2024